Cytori Therapeutics, (CYTX) Posts Q4 Loss of 12, Wider than Views

Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported Q4 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $2.08 million versus the consensus estimate of $3.7 million.

For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• KULR Technology Group (KULR) Misses Q2 EPS by 39c
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c